79357252 - FRIESLANDCAMPINA

Information

  • Trademark
  • 79357252
  • Serial Number
    79357252
  • Registration Number
    7318328
  • Filing Date
    March 23, 2022
    2 years ago
  • Registration Date
    March 05, 2024
    10 months ago
  • Transaction Date
    June 06, 2024
    7 months ago
  • Status Date
    March 05, 2024
    10 months ago
  • Published for Opposition Date
    December 19, 2023
    a year ago
  • Location Date
    March 05, 2024
    10 months ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    LOZEAU, BRANDON THOMAS
  • Attorney Docket Number
    T271189WUS
    Attorney Name
    Roberto Ledesma
    Law Office Assigned Location Code
    N90
  • Owners
Mark Drawing Code
4
Mark Identification
FRIESLANDCAMPINA
Case File Statements
  • GS0301: Coffee, tea and herbal tea-based beverages, cocoa-based beverages, chocolate-based beverages, chocolate-based beverages with milk; rice pudding; semolina-based products, namely, semolina pudding, oatmeal porridge, groats for human food; sauces, cream-based sauces and butter-based sauces; dessert puddings, Bavarian cream, chocolate mousse; custard; desserts included in this class, namely, tiramisu, crème brûlée, crème caramel; powders and preparations for making cappuccino, cocoa, chocolate, coffee and tea beverages
  • GS0291: beverages containing primarily dairy or of plant- or nut-based dairy substitutes, namely, dairy-based beverages, plant-based milk substitute and nut milk-based beverages; dairy products for dietetic use other than for medical use, namely, lactose-free milk, lactose-free cheese, low-fat milk, low-fat cheese; dairy-based spreads for bread; milk; fermented dairy products, namely, fermented milk; milk powder; condensed milk; evaporated milk; buttermilk; protein milk; yogurt and yogurt products, namely, yogurt drinks, Greek yogurt; cottage cheese, soft white cheese; quark; cheese and cheese products, namely, cheese spreads, cheese dips; cream, whipped cream, sour cream, coffee creamer; plant- and nut-based substitutes for cheese, cream, whipped cream and coffee creamer; edible oils and fats; butter, butter ghee; desserts based on dairy or on plant- or nut-based milk substitutes, namely, dairy-based chocolate food beverages, plant-based milk substitute and nut milk-based chocolate food beverages; dairy-based meat substitutes; breakfast drinks consisting primarily of dairy products, plant-based dairy replacements or nut based dairy replacements, namely, dairy-based breakfast drinks, plant-based milk substitute and nut milk-based breakfast drinks; snacks based on dairy products, plant-based dairy replacements or nut based dairy replacements, namely, snacks consisting of primarily dairy-based meat; dairy substitutes, namely, non-dairy milk substitutes; dairy product substitutes, namely, artificial cream; plant-based dairy substitutes, namely, plant-based milk substitutes; nut-based dairy substitutes, namely, nut-based milk substitutes; panna cotta
  • GS0051: Pharmaceuticals, namely, pharmaceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for pharmaceutical purposes, namely, biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for medical purposes, namely, biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; hyaluronic acids for pharmaceutical purposes; hyaluronic acids for medical purposes; amino acids for pharmaceutical purposes; amino acids for medical purposes; lactose for pharmaceutical purposes; lactose for medical purposes; cellulose esters for pharmaceutical purposes; microcrystalline cellulose for pharmaceutical purposes; nutraceuticals for use as a dietary supplement; nutraceuticals for therapeutic purposes; food supplements; dietary food supplements; vitamin preparations in the nature of food supplements; dietary supplements in form of vitamins and minerals; dietetic preparations and beverages adapted for medical purposes; food for babies; milk powder for infants, namely, powdered milk for babies; infant formula milk powder, namely, powdered milk for babies
  • GS0011: Chemical and organic compositions for use in the manufacture of pharmaceuticals; chemical and organic excipients for use in the manufacture of food and beverages; chemical and organic compositions for use in the manufacture of food and beverages; lactose as a raw material to be used in the manufacture of foodstuffs; lactose for the food industry; lactose for industrial purposes; plant extracts for use in food and beverage industry; food protein as a raw material for the food industry; plant proteins as a raw material for the food industry; plant proteins in powder form for industrial purposes; proteins for industrial purposes; casein and caseinates for industrial purposes; protein from pulses for use as an ingredient in the manufacture of dietary supplements
Case File Event Statements
  • 12/8/2022 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 12/9/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 12/13/2022 - 2 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 1/6/2023 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/9/2023 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/10/2023 - 2 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/3/2023 - a year ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/3/2023 - a year ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 3/19/2023 - a year ago
    9 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV
  • 3/29/2023 - a year ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 4/11/2023 - a year ago
    11 - CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED Type: CREV
  • 4/17/2023 - a year ago
    12 - ATTORNEY REVIEW COMPLETED Type: ATRV
  • 8/30/2023 - a year ago
    13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/30/2023 - a year ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/31/2023 - a year ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/14/2023 - a year ago
    16 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG
  • 11/6/2023 - a year ago
    17 - LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: LIMN
  • 11/16/2023 - a year ago
    18 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 11/16/2023 - a year ago
    19 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 11/16/2023 - a year ago
    20 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 11/16/2023 - a year ago
    21 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 11/17/2023 - a year ago
    22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/27/2023 - a year ago
    23 - CORRECTION CREATED FOR IB Type: CRCR
  • 11/27/2023 - a year ago
    24 - CORRECTION SENT TO IB Type: CRSN
  • 11/29/2023 - a year ago
    25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/29/2023 - a year ago
    27 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 11/29/2023 - a year ago
    26 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 12/19/2023 - a year ago
    28 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/19/2023 - a year ago
    29 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/5/2024 - 10 months ago
    31 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/5/2024 - 10 months ago
    32 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 6/6/2024 - 7 months ago
    35 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 6/6/2024 - 7 months ago
    33 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 6/6/2024 - 7 months ago
    34 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 1/2/2024 - a year ago
    30 - NOTIFICATION PROCESSED BY IB Type: GPNX